Wednesday, July 22

Browsing: proteomicsfrom

Research

Dissecting non-small cell lung cancer (NSCLC) with blood proteomics—from surgical to immunotherapeutic responses

By NewsCancerMay 12, 20260

NSCLC remains a leading cause of cancer-related mortality, with limited biomarkers to guide surgical and immunotherapeutic intervention. This study leveraged…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia

The Story of Immune Checkpoint Inhibitors and Immunotherapy

Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy

Browsing: proteomicsfrom

Dissecting non-small cell lung cancer (NSCLC) with blood proteomics—from surgical to immunotherapeutic responses

Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia

The Story of Immune Checkpoint Inhibitors and Immunotherapy

Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy

Considering CAR T vs Bispecific Antibodies in R/R Follicular Lymphoma

Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia

The Story of Immune Checkpoint Inhibitors and Immunotherapy

Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy

Considering CAR T vs Bispecific Antibodies in R/R Follicular Lymphoma

Latest Post

Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia

The Story of Immune Checkpoint Inhibitors and Immunotherapy

Delayed Neurotoxicity Remains a Challenge in CAR T-Cell Therapy

Subscribe to Updates

What's Hot

Browsing: proteomicsfrom